Parenteral Drugs India Limited announced earnings results for the fourth quarter ended March 31, 2019. For the fourth quarter, the company announced total revenue was INR 37.898 million compared to INR 466.156 million a year ago. Net loss was INR 719.581 million compared to INR 211.020 million a year ago. Basic loss per share was INR 24.13 compared to INR 7.08 a year ago. For the full year, total revenue was INR 334.630 million compared to INR 2,187.031 million a year ago. Net loss was INR 1,479.044 million compared to INR 1,189.420 million a year ago. Basic loss per share was INR 49.61 compared to INR 39.89 a year ago.